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Abstract 
INTRODUCTION: Stroke is an established risk factor for all-cause dementia, though meta-
analyses are needed to quantify this risk.  
METHODS: We searched Medline, PsycINFO and Embase for studies assessing prevalent or 
incident stroke versus a no-stroke comparison group and the risk of all-cause dementia. 
Random effects meta-analysis was used to pool adjusted estimates across studies and meta-
regression was used to investigate potential effect modifiers. 
RESULTS: We identified 36 studies of prevalent stroke (1.9 million participants) and 12 
studies of incident stroke (1.3 million participants). For prevalent stroke, the pooled hazard 
ratio for all-cause dementia was 1.69 (95% CI: 1.49-1.92; p<0.00001; I2 = 87%). For incident 
stroke, the pooled risk ratio was 2.18 (95% CI: 1.90-2.50; p<0.00001; I2 = 88%). Study 
characteristics did not modify these associations, with the exception of sex which explained 
50.2% of between-study heterogeneity for prevalent stroke. 
DISCUSSION:  Stroke is a strong, independent, and potentially modifiable risk factor for all-
cause dementia.  
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1. Introduction 
Stroke is associated with the risk of cognitive impairment and dementia [1-3]. A systematic 
review [3] of 16 studies conducted in 2008 concluded that both history of and new stroke was 
associated with risk of developing all-cause dementia, although they were not able to conduct 
a meta-analysis at the time due to methodological heterogeneity in the included studies. A 
meta-analysis [4] of 30 studies conducted in 2009 established that dementia prevalence in 
symptomatic stroke patients increased from 10% before first stroke to 20% soon after first 
stroke, and more than a third had dementia after recurrent stroke. More recently, a meta-
analysis [5] of six studies conducted in 2013 established that stroke is a moderately strong risk 
factor for Alzheimer’s disease (AD) (risk ratio (RR) = 1.59, 95% CI = 1.25 – 2.02). Taken 
together these studies highlight the central causal role of symptomatic stroke, rather than 
underlying vascular risk factors. Given the current lack of disease modifying treatments and 
the complexity of multiple pathologies contributing to dementia, estimating the excess risk of 
dementia following stroke has the potential to inform preventive strategies to reduce the global 
burden of dementia. A recent umbrella review identified that no previous meta-analysis of the 
relationship between stroke and all-cause dementia had been undertaken [6]. A large number 
of original studies have been published since the systematic review conducted in 2008 [3], our 
objective was therefore to conduct the first meta-analysis of the relationship between stroke 
and all-cause dementia risk.  
 
2. Methods 
We updated the systematic review conducted by Savva and colleagues [3] and performed 
study-level random effects meta-analyses following general guidance provided by the Centre 
for Reviews and Dissemination (CRD, UK) [7]. 
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2.1 Search strategy and selection criteria 
Following the methods of the previous systematic review [3] and our pre-defined protocol, we 
developed search strategies for Medline, PsycINFO and Embase (via OvidSP) including 
subject headings and free text terms relevant to dementia, stroke and study design (see 
Appendix A, Methods and Fig. A1, A2, A3). We conducted our searches on 27 April 2017 
(EK) restricting them to studies published after 2008 to avoid overlap with the previous 
systematic review which searched up to 31 December 2008 [3]. We also conducted backward 
and forward citation searches (via Web of Science; EK, IL) of publications included through 
our searches and in the previous systematic review [3]. We included prospective studies 
published in English investigating the association between prevalent or incident stroke and 
incident all-cause dementia. The population was adults aged 18 years or older, and the 
comparison group was adults without prevalent or incident stroke. Prevalent stroke was defined 
as history of previous stroke at baseline and incident stroke as stroke occurrence during follow-
up. Studies with outcomes other than all-cause dementia, i.e. dementia subtypes or dementia-
related outcomes (e.g. neuroimaging or biomarkers) were excluded. We also excluded studies 
with no comparison group or comparison group other than no stroke (i.e. stroke subtype), 
animal studies, case reports, narrative reviews, letters, editorials, opinions, book chapters, 
conference abstracts and duplicate publications using the same data. Following the pre-defined 
inclusion and exclusion criteria, two reviewers (EK, IL) independently screened titles and 
abstracts, and full-texts. Discrepancies were resolved by discussion with a third reviewer 
(DJL).  
Key data were extracted by one reviewer (EK) and checked by the second (IL or SFM). We 
also contacted corresponding authors of 18 studies for clarification or where relevant data were 
not fully reported and received additional data or clarification for 13 studies (see Appendix A, 
Methods for details). Two reviewers (EK, IL) independently assessed the risk of bias of 
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included studies using the Quality Assessment Tool for Quantitative Studies [8] with 
discrepancies resolved by discussion. For each included study components of the tool (selection 
bias, study design, confounders, blinding, data collection methods, and withdrawals and drop-
outs) and overall risk of bias were rated as “strong”, “moderate” or “weak”. 
2.2 Data analysis 
Studies were categorised by exposure into those investigating either prevalent or incident 
stroke. Total number of participants and stroke events were reported based on analytic sample 
size unless otherwise specified. We conducted random effects meta-analyses using the generic 
inverse-variance method [9] in recognition of the inherent methodological heterogeneity across 
studies. We used the Review Manager 5.3 software [10] to pool compatible estimates for the 
associations between prevalent or incident stroke and incident all-cause dementia. We 
prioritised fully-adjusted estimates of effect and extracted unadjusted results only if adjusted 
models were not available. When a group of studies entered in meta-analysis reported results 
as hazard ratios (HRs) and risk ratios (RRs), we presented the pooled estimate as a RR [11]. In 
separate meta-analyses, we combined results from studies reporting odds ratios (ORs). 
Adjusted estimates of effect were used for our primary analyses. In secondary analyses, we 
used summary estimates from unadjusted results. In sensitivity analyses, we excluded studies 
whose samples were limited to participants with prevalent mild cognitive impairment (MCI) 
or diabetes at baseline, or combined prevalent or incident stroke with transient ischemic attack 
(TIA). Where results were provided separately on the basis of APOE genotype (one or more 
ε4 allele versus none) or sex (male/female), we also present these additional stratified results. 
We investigated heterogeneity using Cochran’s Chi-squared test and the I-squared statistic 
[12]. Funnel plots were obtained to evaluate the presence of publication bias. Where estimates 
from three or more studies were pooled, we reported 95% prediction intervals (PIs) which 
indicate the 95% range of true HRs (RRs or ORs) across settings that are similar to those in the 
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pooled studies [13]. Studies that could not be included in meta-analyses due to important 
differences in the outcome (e.g. early- vs. late-onset dementia) or statistical methods used were 
synthesised narratively.  
We used meta-regression to investigate the effects of previously identified potential moderators 
of the relationship between stroke and dementia [5]. For prevalent stroke, we fitted meta-
regression models by regressing the pooled HR of dementia risk on: study setting (community 
vs. non-community), inclusion of TIA in stroke assessment/diagnosis (yes/no), dementia 
diagnostic criteria used (DSM/ICD, other), stroke assessment based upon self-report only 
(yes/no), adjustment for at least one vascular risk factor (yes/no), mean/median age of 
participants in years, proportion of male participants (%), year at baseline examination, length 
of follow-up in years, and study quality (strong vs. moderate/weak). For incident stroke, we 
fitted meta-regression models by regressing the pooled RR of dementia risk on inclusion of 
TIA in stroke assessment/diagnosis, mean/median age of participants in years, proportion of 
male participants (%), year at baseline examination, length of follow-up in years, and study 
quality (strong vs. moderate/weak) (there were an inadequate number of studies to investigate 
the other potential moderators). Meta-regression analyses were performed using the ‘metareg’ 
command in Stata software, version 14.2 (StataCorp, College Station, TX, USA).  
 
3. Results 
Database searches resulted in 11,129 records. After removing duplicates, we screened 6,893 
titles and abstracts and identified 99 for full-text review. Twenty six studies met our eligibility 
criteria. We also included 16 out of the 17 studies from the previous systematic review [3] and 
four studies identified via backward and forward citation searches (Fig. 1). We excluded the 
study by Reitz and colleagues using data from the Rotterdam Study [14] due to overlap with a 
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more recent publication from the same cohort [15] which had longer follow-up and a larger 
sample size.  
The characteristics of the 46 included studies are shown in Table 1 and Appendix B, Tables B1 
and B2. Nineteen studies were based in America, 16 in Europe, six in Asia, four in Australia 
and one was multinational. Thirty six studies included dementia-free participants at baseline, 
five studies reported they included cognitively normal population samples, and five studies 
recruited participants with mild cognitive impairment (MCI) or other cognitive impairment at 
baseline. Reporting of follow-up varied between studies (e.g. median, mean or maximum 
follow-up) and length ranged from nine months to 25 years. Twenty-four studies assessed 
stroke through self- or informant-report, and 15 studies reported adjudicated dementia 
diagnosis using DSM or ICD criteria [16-18]. Five studies assessed both stroke and dementia 
solely through medical records (Appendix B, Tables B3 and B4).  
3.1 Risk of bias 
Sixteen studies were rated as of overall strong quality, 20 as moderate and ten as weak 
(Appendix B, Table B5). Of the moderate-quality studies, six showed potential bias in the 
relevant confounders controlled for in the design or analysis, five showed potential bias in data 
collection methods and a further five studies were subject to selection bias. The weak-quality 
studies showed high risk of bias primarily due to a combination of selection bias (n=4), data 
collection methods (n=5), confounders (n=8) and attrition bias (n=3). 
3.2 Prevalent stroke 
Thirty four prospective cohort studies [19-52] (including three cohort studies of patients with 
MCI [19,24,28] and one diabetic cohort [22]) and two observational analyses of cohorts 
recruited for randomized controlled trials (RCTs) [53,54] investigated the association between 
prevalent stroke and incident all-cause dementia (around 1.9 million participants and 240,471 
8 
 
stroke events; Appendix B, Table B1). Most studies included older adults with an analytic 
sample size ranging from 52 [28] to 486,640 [25]. Two studies [26,50] included only women.  
Pooled results from 22 cohorts of dementia-free participants at baseline (1,885,536 participants 
and 237,886 stroke events) indicated a higher adjusted risk of incident dementia in participants 
with prevalent stroke compared to those without stroke (pooled HR = 1.69, 95% CI: 1.49 – 
1.92, p<0.00001, I2 = 87%; 95% PI: 1.17 – 2.21; Fig. 2). Visual inspection of the funnel plot 
indicated no sign of publication bias (Appendix B, Fig. B4). In a sensitivity analysis, we 
excluded results provided by Walters and colleagues [49] for those aged 80 to 95 due to 
correlation with results reported from the same cohort for those aged 60 to 79. The pooled HR 
remained almost unchanged (1.75, 95% CI: 1.55 – 1.97, p < 0.00001; I2 = 78%; 95% PI: 1.33 
– 2.17). In further sensitivity analyses, we excluded studies including participants with MCI 
[19,24,32,40] or combining stroke with TIA [24,30,44,48,49,54]. In both cases, pooled 
estimates remained essentially unchanged (pooled HR = 1.71, 95% CI: 1.49 – 1.95, p < 0.001; 
I2 = 89%; 95% PI: 1.17 – 2.25, and pooled HR = 1.69, 95% CI: 1.46 – 1.96, p < 0.001; I2 = 
51%; 95% PI: 1.23 – 2.15 respectively; Appendix B, Fig. B5.1, B5.2). Meta-regression 
analyses showed little evidence of effect modification on the basis of study setting (p=0.82), 
inclusion of TIA in stroke assessment/diagnosis (p=0.89), dementia diagnostic criteria used 
(p=0.37), stroke assessment based upon self-report only (p=0.59), adjustment for at least one 
vascular risk factor (p=0.92), mean/median age of participants (p=0.48), year at baseline 
examination (p=0.47), length of follow-up (p=0.73), or study quality (p=0.75). There was 
however some evidence for effect modification by sex, indicating that the risk of dementia 
corresponding to prevalent stroke was higher in men in comparison to women (p=0.04). Effect 
modification by sex explained around half of the observed between-study heterogeneity (males: 
HR = 1.02, 95% CI: 1.00 – 1.03, p=0.04; females: HR = 0.98, 95% CI: 0.97 – 0.99, p=0.04; 
adjusted R2=50.2%). 
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Eight studies [21-23,33,35,46,51,52] reported adjusted ORs instead of HRs (11,336 
participants and 1,001 stroke events). The pooled estimate indicated increased odds of incident 
dementia in those with prevalent stroke compared to no prevalent stroke (pooled OR = 1.53, 
95% CI: 1.30-1.80, p<0.00001, I2 = 0%; 95% PI: 1.22 – 1.84; Fig. 3). In a sensitivity analysis, 
we excluded the study by Bruce and colleagues [22] as it included only participants with 
diabetes. The estimate remained essentially unchanged (pooled OR = 1.57, 95% CI: 1.29-1.91, 
p<0.001; I2= 11%; 95% PI: 1.09 – 2.05).  
In a secondary analysis, the pooled estimate for three studies [26,28,42] reporting unadjusted 
results (2,795 participants and 262 stroke events) indicated little evidence of an association 
between prevalent stroke and incident dementia (pooled RR = 1.22, 95% CI: 0.50 – 2.99, 
p=0.66; I2 = 74%; 95% PI: -10.38 – 12.82; Appendix B, Fig. B5.3). One additional study [47] 
reported dementia risk according to occurrence of recurrent stroke: both prevalent and recurrent 
stroke contributed to increased risk of incident dementia compared to absence of stroke 
(Appendix B, Table B3). 
Three additional studies [39,41,50] could not be included in the meta-analyses as they did not 
fully report their results [41,50] or used standardised morbidity ratio as an effect size which 
could not be combined with existing estimates [39]. These studies all indicated prevalent stroke 
was associated with greater risk of incident dementia. We also excluded the study by Hobson 
and colleagues [36] from the meta-analysis because it was unclear whether it included 
participants with prevalent dementia at baseline. The authors reported that controlling for 
baseline dementia, prevalent stroke more than doubled the risk of incident dementia although 
there was a high degree of uncertainty surrounding their estimate (RR = 2.14, 95% CI: 0.64 – 
7.13; Appendix B, Table B3).  
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3.3 Incident stroke 
Twelve prospective cohort studies [15,37,42,55-63] investigated the association between 
incident stroke and incident all-cause dementia (around 1.3 million participants and 131,217 
stroke events; Appendix B, Table B2). The majority of studies included older adults and the 
analytic sample size ranged from 339 [62] to 799,069 [60]. One study [61] focused on the 
association with early-onset dementia in men. In one additional study [60] 98% of the 
participants were men. 
When we combined adjusted results from eight studies [15,37,55,57,59,60,62,63] (849,059 
participants and 125,947 stroke events), the pooled estimate indicated that incident stroke more 
than doubled the risk of developing all-cause dementia compared to no incident stroke (pooled 
RR = 2.18, 95% CI: 1.90 – 2.50, p<0.001; I2 = 88%; 95% PI: 1.67 – 2.69, Fig. 4). No obvious 
sign of publication bias was detected by visual inspection of the funnel plot (Appendix B, Fig. 
B4).  None of the studies investigating incident stroke reported including participants with MCI 
at baseline. In a sensitivity analysis, we excluded three studies [15,62,63] combining stroke 
with TIA. The pooled estimate was in the same direction though stronger and the degree of 
heterogeneity between studies was slightly reduced (pooled RR = 2.41, 95% CI: 2.22 – 2.62, 
p<0.001; I2 = 65%; 95% PI: 2.09 – 2.73; Appendix B, Fig. B6.1). One study [56] reporting an 
adjusted OR could not be included in the meta-analyses, although their findings also suggested 
increased odds of incident dementia in those with incident stroke compared to no incident 
stroke (Appendix B, Table B4). Meta-regression analyses indicated there was little evidence 
that inclusion of TIA in stroke assessment/diagnosis (p=0.49), mean/median age of participants 
(p=0.16), year at baseline examination (p=0.37), length of follow-up (p=0.32), or study quality 
(p=0.49) modified dementia risk. 
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In a secondary analysis, the pooled estimate for two studies [42,58] reporting unadjusted results 
(1,007 participants and stroke events) indicated that incident stroke almost tripled the risk of 
dementia compared to no incident stroke (pooled RR = 2.96, 95% CI: 1.81 – 4.84, p<0.001; I2 
=33%; Appendix B, Fig. B6.2). A study focusing on early-onset dementia in men [61] indicated 
that incident stroke almost tripled the risk of developing early-onset dementia (HR = 2.96, 95% 
CI: 2.02 – 4.35; Appendix B, Table B4).  
 
3.4 APOE genotype 
Three studies [30,38,63] reported the combined effect of prevalent stroke and APOE ε4 on all-
cause dementia risk for combinations of stroke and APOE genotype (Table 2). Prevalent stroke 
was associated with a significantly increased risk of dementia for APOE ε4 non-carriers in two 
out of three studies [30,63], and the hazard ratio for the non-significant association was in the 
same direction [38]. Similarly, two out of three studies of prevalent stroke in APOE ε4 carriers 
indicated a significantly increased risk of dementia [38,63], and the hazard ratio of the non-
significant association was again in the same direction [30]. However, there was no consistent 
difference in the effect sizes observed between APOE ε4 carriers and non-carriers for prevalent 
stroke. 
Two studies [57,63] reported the combined effect of incident stroke and APOE ε4 on all-cause 
dementia risk for combinations of stroke and APOE genotype (Table 2). Incident stroke was 
associated with a significantly increased risk of dementia for APOE ε4 non-carriers in both 
studies. One out of two studies found that incident stroke was associated with a significantly 
increased risk of dementia for APOE ε4 carriers [63], though the hazard ratio for the other 
study was in the same direction [57]. There was no consistent difference in the effect sizes 
observed between APOE ε4 carriers and non-carriers for incident stroke. 
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3.5 Sex-stratified findings  
Three studies [25,43,57] reported additional results for incident all-cause dementia stratified 
by sex (Appendix B, Table B6). One large cohort study [25] suggested a stronger association 
in men whereas two further studies [43,57] did not support a sex difference in the effect size. 
 
4. Discussion 
The results of our meta-analyses show that both prevalent and incident stroke are strong 
independent risk factors for all-cause dementia. However, significant between-study 
heterogeneity was observed. Associations persisted when excluding studies that included 
participants with prevalent MCI or combined diagnosis of stroke with TIA. Stratified analyses 
did not suggest a consistent difference in the effect sizes observed between APOE ε4 carriers 
and non-carriers for prevalent or incident stroke. Meta-regression analyses suggested that 
heterogeneity was not explained by a range of demographic factors or study characteristics, 
with the exception of sex which explained around half of the between-study variance observed 
for prevalent stroke. 
Our meta-analysis extends the findings of the previous systematic review by Savva [3] and 
colleagues who concluded that stroke approximately doubles the risk of incident dementia in 
older adults. We included a larger number of prospective studies published since then (46 vs. 
17) yielding a sample of nearly 3 million older adults and we were able to provide pooled 
estimates for both prevalent and incident stroke in relation to risk of all-cause dementia. Our 
results are also in line with a recent meta-analysis [5] of six studies reporting that participants 
with a history of stroke had 59% increased risk of developing AD compared with controls. 
However, the aforementioned study did not include all-cause dementia as an outcome. 
Associations with increased rates of post-stroke dementia are well known and have been 
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previously synthesised [4]; our analysis extends these findings beyond post-stroke incidence 
rates by providing pooled estimates for the risk of developing dementia compared to stroke-
free populations.  
Significant associations between stroke and higher risk of incident dementia were observed 
even after included studies adjusted for common modifiable risk factors for stroke such as 
hypertension, diabetes, myocardial infarction, and heart disease. Current evidence on the 
excess risk of stroke is based on observational data and since it is not possible to randomize 
participants to stroke events, RCTs have only indirectly examined the effect of stroke 
prevention interventions on dementia risk reduction. For example, trials assessing the effect of 
antihypertensive therapy have reported reduced incidence of all-cause dementia, vascular 
dementia and AD but results are inconsistent [64,65]. Similarly, prospective studies on 
anticoagulation for secondary prevention of stroke in older adults with atrial fibrillation have 
shown variable effects on dementia risk [66,67]. Certain characteristics of stroke may explain 
the increased risk of dementia in stroke survivors. Studies investigating stroke subtypes have 
implicated both lacunar and haemorrhagic strokes as predictors of post-stroke dementia [4,68], 
but evidence is mixed and variation in stroke subtyping methods may explain conflicting 
findings in the literature. The presence of multiple lesions, the volume of infarcts and the 
location of stroke (e.g. left hemisphere) have also been identified as risk factors for post-stroke 
dementia [4]. Neuroimaging studies have highlighted the role of medial temporal lobe atrophy 
and leukoaraiosis: extensive white matter changes related to subcortical stroke injury may 
increase the risk of memory decline and contribute to cortical grey matter thinning thereby 
increasing the risk of cognitive impairment [69]. Moreover, it has been suggested that stroke 
may trigger a neurodegenerative process by disrupting amyloid clearance [70] or by activating 
autoimmune responses [71] to brain antigens produced post-stroke. It is also possible that 
existing AD pathology may predispose to stroke: neuroinflammation and compromised 
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integrity of arterial walls related to accumulation of amyloid may result in greater risk of 
cerebrovascular events and increased infarct size [72]. It is therefore plausible that ongoing 
cerebrovascular injury due to vascular risk factors, immune processes, and pathogenic 
mechanisms may contribute to dementia risk after stroke.  
This is the first meta-analysis to investigate the association of prevalent and incident stroke 
with incident all-cause dementia. The strengths of this study include the comprehensive search 
strategy including major electronic databases, backward and forward citation searching, and 
contacting authors for relevant data. We included publications in which stroke was not the main 
variable of interest and were able to identify studies reporting non-significant results to 
counteract potential publication bias. We also performed meta-regression analyses to explore 
potential moderators that may explain between-study heterogeneity. We provide up to date 
evidence supporting associations between stroke and increased risk of dementia based on a 
large number of studies with long follow-up periods and millions of participants.  
However, the present results should be considered in light of the limitations of the included 
original studies. Some studies included selective samples, for example only men or women, 
volunteers, spouses of participants with stroke and subsamples enrolled in specific projects. 
Although most studies reported dementia-free participants at baseline, we cannot exclude the 
possibility that more studies than those already identified in our analysis included populations 
with MCI and cognitive impairment. These biases may have led to an overestimation of the 
association between stroke and all-cause dementia. Nonetheless, current results were robust to 
sensitivity analysis when we excluded studies with known MCI cohorts (i.e. highly similar 
effect size estimates). In addition, not all studies were specifically designed to investigate the 
association between prevalent or incident stroke and dementia. This translates into 
methodological differences in sample selection, stroke assessment and dementia diagnosis 
criteria, length of follow-up, statistical analysis plans and adjustments to account for potential 
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confounders. We were not able to incorporate important potential modifiers such as ethnicity 
and education in our meta-regression analyses due to inconsistent and incomplete reporting in 
the original studies. Clear and comprehensive reporting of information related to ethnic 
breakdown and educational level will facilitate harmonization of these potential modifiers 
across studies and subsequently strengthen future meta-regression analyses. Only three studies 
used neuroimaging to define stroke status, and it is possible that techniques such as T2-
weighted and FLAIR magnetic resonance imaging (MRI), and 18F-2-fluoro-2-deoxy-D-glucose 
(FDG) positron emission tomography (PET) [73] may help to reduce unexplained between-
study variability by improving the quantification of stroke-related pathology which in turn 
increases dementia risk. Similarly, unassessed variance in participant characteristics and the 
incidence of dementia unrelated to stroke may also have contributed to between-study 
variability.   
Finally, dementia may develop many years before the diagnosis, and in research studies 
diagnosis is usually made during assessments at discrete times. Therefore, it is difficult to 
determine the exact dementia onset and as such the temporality of the association in studies of 
incident stroke and dementia especially in those with a long duration of follow-up. However, 
the stronger association observed for incident stroke suggests risk is greater near the time of 
stroke occurrence. More detailed reporting of the interval between stroke occurrence and 
dementia diagnosis in future studies will help to better characterise the role of time since stroke 
in the risk of dementia.  
In conclusion, this systematic review and meta-analysis provides evidence that stroke is a 
strong independent risk factor for dementia. Given the consequences for people with dementia 
and their families and the significant implications for social and healthcare costs, stroke 
prevention strategies should be integrated in multimodal health interventions to reduce 
dementia risk.  
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Table 1. Summary of data included in the systematic review* 
  
Studies, N
 † 
 
Participants, N 
 
Stroke events, N 
All studies 46 3,242,618 371,688 
  Prevalent stroke 36 1,903,733 240,471 
  Incident stroke 12 1,338,885 131,217 
Settings    
  Community 36 1,332,276 225,588 
  Primary care 2 930,771 59,241 
  Secondary care  3 422 64 
  Other‡  5 979,149 86,795 
Number of participants is based on analytic sample size and number of stroke events was estimated based on available information if not clearly reported in 
the original study. * Details of individual studies are shown in Appendix B, Tables B1 to B4. †Two studies reported on both prevalent and incident stroke 
exposures. ‡Two studies included participants from both primary and secondary care populations, two additional studies included participants from both 
secondary and community populations, and one study included participants from a military register. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
25 
 
 
 
 
 
 
 
 
 
 
 
Table 2. Results for the effect of stroke and APOE ε4 on incident all-cause dementia compared with population without stroke and APOE ε4 
 APOE ε4- & Stroke- APOE ε4- & Stroke+ APOE ε4+ & Stroke- APOE ε4+ & Stroke+ 
Study Effect size (95% CI) Effect size (95% CI) Effect size (95% CI) Effect size (95% CI) 
Prevalent stroke 
Dodge et al. (2011)30 Reference  HR = 2.64 (1.27-5.51) Reference HR = 1.43 (0.54-3.84) 
Jin et al. (2008)38 Reference HR = 1.33 (0.73-2.43) HR = 2.06 (1.42-2.99) HR = 2.57 (1.11-5.94) 
Zhu et al. (2000)63  Reference HR = 2.7 (1.6-4.8) HR = 1.7 (1.2-2.4) HR = 2.7 (1.1-6.8) 
Incident stroke 
Ivan et al. (2004)57 Reference HR = 3.4 (2.0-5.8) Reference HR = 1.2 (0.4-4.1) 
Zhu et al. (2000)63 Reference HR = 2.3 (1.3-4.1) HR = 1.7 (1.1-2.4) HR = 4.6 (2.0-10.6) 
APOE, Apolipoprotein E; CI, confidence interval; HR, hazard ratio.  
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Figure 1  
 
11129 identified from electronic database searches 
 
4236 duplicates 
6794 excluded after title and abstract screening 
99 full-text articles reviewed for eligibility 
 
73 excluded: 
    8 not prospective 
    3 insufficient information 
    6 overlapping data 
    2 no or inappropriate control group 
  13 no all-cause dementia 
    7 stroke not assessed 
  34 no stroke specific results 
26 eligible articles 
16 included in previous 
systematic review and eligible 
46 included in systematic review 
40 included in meta-analyses 
 
3 identified via backward citation 
searches  
1 identified via forward citation 
searches  
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Figure 3 
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Figure captions 
Fig. 1. Flowchart of search results and study retrieval 
Fig. 2. Meta-analysis of hazard ratios of prevalent stroke compared to no prevalent stroke on 
incident all-cause dementia 
Data presented as hazard ratios with corresponding weight for each study in the meta-analysis 
because number of stroke events, dementia cases and total number of participants was not 
always available in original included studies. Hazard ratio estimate for the study by Hayden 
and colleagues [34] was obtained in Review Manager using the generic inverse-variance 
method and is different from that obtained from a discrete-time survival model reported in the 
original study (i.e. HR = 3.23, CI = 1.74-5.64). The appendix shows the corresponding funnel 
plot. IV, inverse-variance estimation method; CI, confidence interval; EC, extended cohort; 
FHS, Framingham Heart Study; HRS, Health and Retirement Study; OC, original cohort; 
SALSA, Sacramento Area Latino Study on Aging.  
 
Fig. 3. Meta-analysis of odds ratios of prevalent stroke compared to no prevalent stroke on 
incident all-cause dementia 
Data presented as odds ratios with corresponding weight for each study in the meta-analysis 
because number of stroke events, dementia cases and total number of participants was not 
always available in original included studies. The appendix shows the corresponding funnel 
plot. IV, inverse-variance estimation method; CI, confidence interval.  
 
Fig. 4. Meta-analysis of risk ratios of incident stroke compared to no incident stroke on incident 
all-cause dementia 
Data presented as risk ratios with corresponding weight for each study in the meta-analysis 
because number of stroke events, dementia cases and total number of participants was not 
always available in original included studies. The appendix shows the corresponding funnel 
plot. IV, inverse-variance estimation method; CI, confidence interval. 
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Appendix A - Methods  
 
Review Protocol 
Review question: Do prospective studies suggest an increased risk of all-cause dementia after stroke?  
Population: Adults (≥18 years) 
Exposure: Prevalent or incident stroke 
Comparators: No stroke  
Outcomes: Incident all-cause dementia 
Search strategy: 
 Searching the following databases: Medline, Embase, PsycINFO (via OvidSP) 
 Backward and forward citation searching of included studies via Web of Science  
Search terms relevant to stroke: stroke, cerebrovascular accident, cerebral vascular accident, brain infarct*, 
cerebral infarct*, risk factor 
Search terms relevant to dementia: dement* 
Study selection criteria: 
Inclusion criteria: 
 Prospective studies on the association between prevalent or incident stroke and incident all-cause 
dementia  
 Only publications in English 
Exclusion criteria: 
 Studies with outcomes that are not directly dementia-related (e.g. neuroimaging or biomarkers) or 
dementia subtypes only 
 Studies with no comparison group or comparison group other than no stroke 
 Animal studies  
 Case reports, narrative reviews, letters, editorials, opinions, book chapters 
 Conference abstracts 
 Duplicate publications using the same data 
 
Study selection: Titles and abstracts will be independently screened by two reviewers (EK & IL) using the 
inclusion/exclusion criteria. Full-texts of potentially relevant studies will be also reviewed independently by the 
same two reviewers. Any discrepancies will be resolved by discussion with involvement of a third reviewer (DJL) 
where necessary.  
Risk of bias assessment: Risk of bias will be assessed independently by two reviewer (EK & IL) using the Quality 
Assessment Tool for Quantitative Studies [8]. Any discrepancies will be resolved by discussion with involvement 
of a third reviewer (DJL) where necessary.  
Data extraction: Key data including study design, assessment of exposures and outcomes, population, adjusted 
and unadjusted estimates of the association between exposure and outcome, and sources of data will be extracted 
by one reviewer (EK) and checked by the second reviewer (IL). Any discrepancies will be resolved by discussion 
with involvement of a third reviewer (DJL) where necessary.  
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Evidence synthesis methods: We will synthesize the evidence on the associations between prevalent or incident 
stroke and all-cause dementia narratively and where appropriate, given consistency between outcome measures, 
comparator groups and reported statistics, using meta-analytic techniques to estimate the summary measures of 
effect on relevant outcomes. A meta-analysis will be conducted using random effects models. Heterogeneity will 
be explored through consideration of the study populations, methods and interventions, by visualisation of results 
and, in statistical terms, by the x2 test for homogeneity and I2 statistic and, where appropriate, using meta-
regression. Small study effects (including publication bias will be visually assessed using funnel plots (if 
appropriate) and quantified using Egger’s statistic. 
 
 
Contacting corresponding authors 
We contacted the corresponding authors of 18 studies [1-18] for clarification or where relevant data was not 
fully reported. We received additional data or clarification for 13 studies [1-5,8,10,12,13,15-18], no response 
from four studies [6,9,11,14]  and for one study [7] the email delivery was unsuccessful. Eleven [1-11] out of 
the 18 studies where corresponding authors were contacted, were included in our systematic review. Three 
studies [12,16,18] were excluded due to data overlapping with other included publications [19,21], two due to 
insufficient data [14,15] one due to combining stroke with other conditions [13] and one due to no stroke-
specific results [17]. 
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Appendix A - Search strategies 
 
1     exp Stroke/ (107761) 
2     stroke.ti,ab. (191763) 
3     (poststroke or (post adj stroke)).ti,ab. (10109) 
4     (cerebrovascular adj (accident or accidents)).ti,ab. (6037) 
5     (cerebral adj vascular adj (accident or accidents)).ti,ab. (1020) 
6     ((brain or cerebral) adj infarct*).ti,ab. (18217) 
7     (risk adj (factor or factors)).ti,ab. (467918) 
8     exp Dementia/ (140757) 
9     dement*.ti,ab. (90703) 
10     prospective*.ti,ab. (576871) 
11     longitudinal.ti,ab. (192206) 
12     predict*.ti,ab. (1255001) 
13     inciden*.ti,ab. (742390) 
14     (determinant or determinants).ti,ab. (200190) 
15     (hazard or hazards).ti,ab. (167706) 
16     1 or 2 or 3 or 4 or 5 or 6 or 7 (675873) 
17     8 or 9 (173398) 
18     10 or 11 or 12 or 13 or 14 or 15 (2718880) 
19     16 and 17 and 18 (5199) 
20     limit 19 to yr="2009 -Current" (2981) 
Fig. A1. Search strategy in Medline 
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1     exp cerebrovascular accident/ (144328) 
2     stroke.ti,ab. (280586) 
3     (poststroke or (post adj stroke)).ti,ab. (15607) 
4     (cerebrovascular adj (accident or accidents)).ti,ab. (8505) 
5     (cerebral adj vascular adj (accident or accidents)).ti,ab. (1305) 
6     ((brain or cerebral) adj infarct*).ti,ab. (24772) 
7     (risk adj (factor or factors)).ti,ab. (637897) 
8     exp dementia/ (286468) 
9     dement*.ti,ab. (124813) 
10     prospective*.ti,ab. (802546) 
11     longitudinal.ti,ab. (235360) 
12     predict*.ti,ab. (1560352) 
13     inciden*.ti,ab. (971263) 
14     (determinant or determinants).ti,ab. (229760) 
15     (hazard or hazards).ti,ab. (219956) 
16     1 or 2 or 3 or 4 or 5 or 6 or 7 (935514) 
17     8 or 9 (304436) 
18     10 or 11 or 12 or 13 or 14 or 15 (3437070) 
19     16 and 17 and 18 (9109) 
20     limit 19 to yr="2009 -Current" (6609) 
Fig. A2. Search strategy in Embase 
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1     exp cerebrovascular accidents/ (17865) 
2     stroke.ti,ab. (27063) 
3     (poststroke or (post adj stroke)).ti,ab. (3735) 
4     (cerebrovascular adj (accident or accidents)).ti,ab. (725) 
5     (cerebral adj vascular adj (accident or accidents)).ti,ab. (201) 
6     ((brain or cerebral) adj infarct*).ti,ab. (1675) 
7     (risk adj (factor or factors)).ti,ab. (68704) 
8     exp dementia/ (64880) 
9     dement*.ti,ab. (55236) 
10     prospective*.ti,ab. (56114) 
11     longitudinal.ti,ab. (88989) 
12     predict*.ti,ab. (373275) 
13     inciden*.ti,ab. (68853) 
14     (determinant or determinants).ti,ab. (44972) 
15     (hazard or hazards).ti,ab. (14483) 
16     1 or 2 or 3 or 4 or 5 or 6 or 7 (95865) 
17     8 or 9 (79601) 
18     10 or 11 or 12 or 13 or 14 or 15 (572422) 
19     16 and 17 and 18 (2456) 
20     limit 19 to yr="2009 -Current" (1539)  
Fig. A3. Search strategy in PsycINFO
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Appendix B - Tables B1-B6 
Table B1. Key characteristics of included studies investigating the association between prevalent stroke and incident all-cause dementia 
Study Country Study 
design 
Setting Follow-up  
in years 
Analytic 
sample size 
No. or % with 
prevalent 
stroke 
Mean baseline age 
(SD) 
Male, % Race/ 
ethnicity  
Education  
Aguilar-
Navarro, 2017 
[19] 
Mexico 
 
MCI 
cohort 
Secondary 
care 
3.5* 125 
  
25 81.7 (6.9) 43 100% 
Mexican  
9.5 (± 6.1)* 
Barnes, 2014 
[20] 
USA (FHS, 
HRS, 
SALSA) 
Multiple 
cohorts 
Community 6 FHS: 2,411 
HRS: 
13,889 
SALSA: 
1125 
FHS: 60 
HRS: 946 
SALSA: 108 
FHS: 72.1 (4.4) 
HRS: 71.3 (4.2) 
SALSA: 71.3 (4.0) 
FHS: 44.5 
HRS: 43.5 
SALSA: 
42.8 
FHS: 100% 
White  
HRS: 88% 
White, 7% 
Black, 5% 
Latino 
SALSA: 
100% Latino 
FHS: <12 yrs, 
13.4% 
HRS: <12 yrs, 
25.8%  
SALSA: <12 yrs, 
71.4% 
Brayne, 1998 
[21] 
United 
Kingdom 
Cohort Primary care 2.4* 376 44† 77+ 36.4   NR <15 yrs: 69.9% 
 
Bruce, 2014 
[22] 
Australia 
(FDS) 
 
Diabetic 
cohort 
Community 14.7* 320 4.7% 57.5 (9.2) 50.3 NR Educated beyond 
primary school: 
81.9% 
Chen, 2011 
[23] 
China Cohort Community 3.9‡ 1,307 45 65+ 56.5 100% Asian ≥High school: 
49.2% 
Secondary 
school: 28.2% 
Primary school: 
22.6% 
Clerici, 
2012[24] 
Italy MCI 
cohort 
Secondary 
care 
 
2.05‡ 245 27 74.1 (6.9) 42 100% White Low (≤5yrs): 
46%, 
High (>5yrs): 
54% 
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Corraini, 2017 
[25] 
Denmark 
(DNPR, 
DPCR) 
Cohort Secondary 
care and 
community 
Stroke cohort: 
4.17‡  
Controls: 
5.06‡ 
486,640 81,107  72‡,§ 52.4§ NR NR 
Crooks, 2008 
[26] 
USA (KPSC 
Medical 
Care 
Program) 
Cohort Community 4 2,249 157 78+ 0 89.6% White, 
4% Black, 
3% Hispanic, 
1.5% 
Asian/Pacific 
islander, 
1.9% Other## 
< High school##: 
9.9% 
High school: 
26% 
Some 
college/trade 
school: 38.5% 
College 
graduate: 25.5% 
de Bruijn, 
2015 [27] 
Netherlands 
(Rotterdam 
Study) 
Cohort Community Original 
cohort: 8.3* 
Extended 
cohort: 8.9* 
Original 
cohort: 
7,003 
Extended 
cohort: 
2,953 
 
Original 
cohort: 175 
Extended 
cohort: 94 
Original cohort: 
69.4 (9.1) 
Extended cohort: 
65.0 (8.3)  
Original 
cohort: 
40.2 
Extended 
cohort: 
43.8 
NR Original cohort: 
Low: 54.3%, 
Intermediate: 
37.3% 
Extended cohort: 
Low: 33.7%, 
Intermediate: 
49.4% 
DeCarli, 2004 
[28] 
USA MCI 
cohort 
 
Secondary 
care 
3.1* 52 12 72.8 71 NR 14.8 (± 2.7)* 
Desmond, 
2002 [29] 
USA Cohort Secondary 
care and 
community 
 
Stroke cohort: 
1.8‡ 
Controls: 5.2‡ 
575 334 70.5 (7.1) 43.3 35.3% Black, 
23.3% 
Hispanic, 
40.4% White, 
1% Other 
11.4 (± 4.8)* 
Dodge, 2011 
[30] 
USA 
(MoVIES) 
Cohort Community 8.0*  822 8.3% 75.8 (4.7) 35.6 NR High school/ 
higher education: 
63.4% 
Downer, 2016 
[31] 
USA (H-
EPESE) 
Cohort Community 10 1,739 88 72.2 (5.7) 42.4 100% 
Mexican-
American 
Low (< 4 yrs): 
28.9%, 
High (≥4 yrs): 
71.1% 
Ganguli, 
2015[32] 
USA 
(MYHAT) 
Cohort Community 5 1,701 75 77.4 (7.3) 37.7 94.7% mixed 
European 
descent 
≥High school: 
86.9% 
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Hassing, 2009 
[33] 
Sweden 
(STR, 
SATSA, 
OCTO-
Twin) 
Cohort Community 40 1,152 17% 52.5 (4.6) 31 NR 7.2 (± 2.3)* 
Hayden, 2006 
[34] 
USA 
(CCSMHA) 
Cohort Community 3.2* 3,264 109 74.0 (6.4) 41.8 Primarily 
White 
13.4 (± 2.9)* 
Hendrie, 2015 
[35] 
USA 
(Indianapoli
s-Ibadan 
Dementia 
Project) 
 
Cohort Community 6.0* 974 122¶ 76.6 (4.9) 30.3 100% African 
Americans 
11.6 (± 2.5)* 
Hobson,  2010 
[36] 
United 
Kingdom 
 
Cohort Primary and 
secondary 
care 
4 114 52 72.9 (8.9)# 56.3#  NR NR 
Hsu, 2017 [37] Taiwan 
(Elderly 
NAHSIT) 
 
Cohort Community 11.0‡ 1,436 70 73.2 (5.4) 51.3 100% Asian 4.9 (± 4.9)* 
Jin, 2008 [38] Canada  
(CSHA) 
 
Cohort Community 4.6‡ 721 72**   65+ 35.1†† NR <8 yrs: 36.2%*** 
Kokmen, 1996 
[39] 
USA Cohort Community 25 Community 
comparison 
971 
971 0-85+ 50 NR NR 
Kuller, 2003 
[40] 
USA (CHS) Cohort Community 6 to 7 2,939 151‡‡ 65+ 40.9‡‡ 85% White, 
15% Black‡‡ 
≥17yrs: 
38.4%†††, 
13-16yrs: 9.6%,  
8-12yrs: 47%, 
<8yrs: 5% 
Li, 1991[41] China Cohort Community 3 825 90§§ 60+ 47.5 
 
~100% Asian NR 
Liebetrau, 
2003 [42] 
Sweden Cohort Community 3 494 93 85+ 28.9 NR High: 25.1% 
Noale, 2013 
[43] 
Italy (ILSA) Cohort Community 7.8‡ 2,501 130 71.3 (5.3)  43.7 NR ≥3 yrs: 70.7% 
40 
 
Peters, 2009 
[53] 
International 
(Hypertensio
n in the 
Very Elderly 
Trial) 
Observati
onal 
analysis of 
RCT 
cohort 
 
Primary and 
secondary 
care 
2* 3,336 216 80+ 39.6 Multinational none: 27.4%, 
primary: 28.2%, 
secondary: 
28.8%, 
higher: 12.3%, 
further: 3.3% 
Qiu, 2010 [44] Sweden 
(Kungsholm
en Project) 
 
Cohort Community 5.1* 1,270 91 81.5 (5.0) 24.9 NR ≥8 yrs: 40.7% 
Simons, 2006 
[45] 
Australia 
(Dubbo 
Study) 
 
Cohort Community 16 2,805 153¶¶ 60+ 
 
44.0 NR NR 
Srikanth, 
2004[46] 
Australia 
(NEMESIS) 
Cohort Community 9 months 179 88 69.9 (13.4) 58.7 NR 10 (±2.4)* 
Srikanth, 2006 
[47] 
Australia 
(NEMESIS) 
 
Cohort  Community 21 months 158 80 69.9 (12.4) 60.0 NR 9.8 (±2.4)* 
Tsai, 2017 
[48] 
Taiwan 
(NHIRD) 
Medical 
records 
cohort 
 
Community 12 415,576 94,468 68.35 (15.54) 60.4 ~100% Asian NR 
Unverzagt, 
2012 [54] 
USA 
(ACTIVE) 
Observati
onal 
analysis of 
RCT 
cohort 
 
Community 5 2,786 194 73.6 (5.9) 24 73.3% White, 
26.7% 
Black/other 
13.6 (±2.7)* 
Walters, 2016 
[49] 
United 
Kingdom 
(THIN) 
Medical 
records 
cohort  
Primary care Aged 60-79: 
5‡ 
Aged 80-95: 
3.8‡ 
Aged 60-
79: 800,013 
Aged 80-
95: 130,382 
Aged 60-79: 
38,976 
Aged 80-95: 
20,221 
Aged 60-79: 65.6 
(6.1) 
Aged 80-95: 84.8 
(3.93) 
Aged 60-
79: 48.3 
Aged 80-
95: 34 
 
NR NR 
Yamada, 
2009[50] 
Japan (AHS) Cohort Community 5.9* 1,637 3.5% 70.95 (7.16) 0 100% Asian Higher education 
(≥7 yrs): 56.5% 
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Yip, 2006[51] United 
Kingdom 
(CFAS) 
 
Cohort  Community 7 4,075 307 65+ 36.9 NR < 9 yrs: 8%, 
9 yrs: 57.5%, 
≥10 yrs: 34.5% 
Zahodne, 2016 
[52] 
USA 
(WHICAP) 
Cohort 
 
Community 6.0* 2,593 184 76.0 (6.2) 31.3 28.6% White, 
32.2% 
African 
American, 
39.2% 
Hispanic 
9.9 (±4.9)* 
ACTIVE, Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE); AHS, Adult Health Study; CCSMHA, Cache County Study of Memory Health and Aging; CFAS, 
Cognitive Function and Ageing Study; CHS, Cardiovascular Health Study; CSHA, Canadian Study of Health and Aging; DNPR, Danish National Patient Registry; DPCR, Danish 
Psychiatric Central Register; ILSA, Italian Longitudinal Study on Aging; FDS, Fremantale Diabetes Study; FHS, Framingham Heart Study; H_EPESE, Hispanic Established Populations 
for the Epidemiologic Study of the Elderly; HRS, Health and Retirement Study; KPSC, Kaiser Permanente Southern California; MoVIES, Monongahela Valley Independent Elders 
Survey; MYHAT, Monongahela-Youghiogheny Healthy Aging Team; NEMESIS, North East Melbourne Stroke Incidence Study; NHIRD, National Health Insurance Research Database; 
OCTO-Twin, Origins of Variance in the Old-Old; RCT, randomised controlled trial; SALSA, Sacramento Area Latino Study on Aging; SATSA, Swedish Adoption/Twin Study of Aging; 
SD, standard deviation; STR, Swedish Twin Registry; THIN, The Health Improvement Network; WHICAP, Washington Heights Inwood Columbia Aging Project. *Mean. †Based upon 
10% of 340 controls and 28% of 36 dementia cases as seen in table 2 of the original study.  ‡Median. §Based upon sample size of 1,290,706. ¶Based upon sample size of 970. #Based upon 
sample size of 190. **Based upon 10% of sample size of 761 and then analytic sample size of 721. ††Based upon sample size of 949. ‡‡ Based upon sample size of 3,375. §§Based upon the 
proportion of risk years as seen in table 4 of the original study multiplied by analytic sample size.  ¶¶Based upon proportion of stroke events for males and females as seen in table 4 of 
publication describing characteristics of the Dubbo study (i.e. Simons L, Simons J, McCallum J, Powell I, Friedlander Y, Heller R. Dubbo study of the elderly: sociological and 
cardiovascular risk factors at entry. Intern Med 1991; 21(5): 701-9). ##Based upon a sample of 2,243 for race/ethnicity, and sample of 2,246 for education. ***Based upon sample of 761. 
†††Based upon sample of 3,370 for education.  
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Table B2. Key characteristics of included studies investigating the association between incident stroke and incident all-cause dementia 
Study Country Study 
design 
Setting Follow-up  
in years 
Analytic 
sample size 
No. with 
incident stroke 
Mean baseline 
age (SD) 
Male, % Race/ ethnicity Education 
Dregan, 2013 
[55] 
United 
Kingdom 
(ELSA) 
Cohort Community 10 10,809 516 64.9 (10.3) 45 NR No qualification: 
42%, 
O-level: 13%, 
A-level: 21%, 
Below degree: 11%, 
Degree level: 11% 
Gamaldo, 
2006 [56] 
USA 
(BLSA) 
Cohort Community 10.0* 335 36 75.1 60.3 93.7% White, 
6% African 
American, 
0.3% Hispanic 
16.8 (±2.8)* 
Hsu, 2017 [37] Taiwan 
(Elderly 
NAHSIT) 
Cohort Community 11.0† 1,436 232 73.2 (5.4) 51.3 100% Asian 4.9 (±4.9)* 
Ivan, 2004 
[57] 
USA (FHS) Cohort Community 10 844 212‡ 78.6 (6.7)‡ 38.7‡ NR High school 
graduate#: 65.2% 
Jin, 2006 [58] Canada 
(CSHA) 
Cohort Community 5 725 109§ 65+ 41 NR NR 
Kim, 2017 
[59] 
South Korea 
(NHIS-
Senior) 
Medical 
records 
cohort 
Community 10 22,792 2,527 60+ 45.2 100% Asian NR 
Li, 2010 [60] USA (US 
Veteran 
Affairs)  
Medical 
records 
cohort 
Community 3† 799,069 120,877 74.9 (5.9) 98.2 2% Hispanic 
white, 
0.2% Hispanic 
black, 
0.1% Native 
American 
Indian 
4% Black, 
0.2% Asian, 
35% White, 
58.5% 
Unknown 
NR 
43 
 
Liebetrau, 
2003 [42] 
Sweden Cohort Community 3 282 39 85+ 28.9¶ NR NR 
Mirza, 2016 
[15] 
Netherlands 
(Rotterdam 
Study) 
Cohort Community 9.9* 12,561 1,463 64.7 (9.6) 41.7 NR Low: 42.2%, 
Intermediate: 
42.5%, 
High:15.3%  
Nordstrom, 
2013 [61] 
Sweden 
(Swedish 
Military 
Service 
Conscription 
Register) 
Medical 
records 
cohort 
Military 
register 
 
37† 488,484 5,086 18.5 (0.8) 100 NR 
 
Elementary school 
only: 22.4% 
Secondary school 2 
or 3 yrs: 47.6% 
University: 26.9%  
Rastas, 2010 
[62] 
Finland 
(Vantaa 
85+) 
Cohort Community 
 
 
9 339 29 88 (2.6) 21.5 NR 4.2 (±2.9)* 
Zhu, 2000 [63] Sweden 
(Kungsholm
en Project) 
Cohort Community 3.05† 1,209 91 81.8 (4.8) 24.5 NR <8 yrs: 50% 
BLSA, Baltimore Longitudinal Study of Aging; CSHA, Canadian Study of Health and Aging; ELSA, English Longitudinal Study of Ageing; FHS, Framingham Heart Study; NAHSIT, 
Nutrition and Health Survey in Taiwan; NHIS-Senior, National Health Insurance Service-Senior. 
*Mean. †Median. ‡Based upon sample size of 1,272. § Based upon stroke incident rate of 3 per 100 person-years. ¶Based upon sample size of 494. #Based upon sample size of 1,239. 
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Table B3. Results of included studies for the association between prevalent stroke and incident all-cause dementia 
Study Dementia 
assessment/diagnosis 
Stroke 
assessment/diagnosis 
Adjustment Effect size  
(95% CI) 
P value 
Aguilar-Navarro, 
2017 [19] 
DSM-IV-TR criteria Stroke in medical records Age, education, diabetes, MMSE, clock-
drawing test, immediate and delayed word 
recall, semantic fluency  
HR = 3.92 (1.37-
11.16) 
0.010 
Barnes, 2014 [20] Across studies: cognitive 
impairment in at least 2 
domains (decline from 
prior levels), daily 
function affected. FHS 
and SALSA: adjudicated. 
HRS: brief cognitive 
battery 
 
NR Age, education, BMI, diabetes, needs help 
with money/medications, depressive 
symptoms 
FHS: HR = 1.24 
(0.39-3.96) 
HRS: HR = 1.75 
(1.45-2.12) 
SALSA: HR = 2.99 
(1.70-5.26) 
NR 
Brayne, 1998 [21] Criteria similar to ICD-10 
applied to CAMDEX 
assessments 
Self- or informant-
reported stroke history 
Age, sex OR = 3.41 (1.49-
7.83) 
<.0.05 
Bruce, 2014 [22] Adjudicated based on 
cognitive assessment and 
hospital/clinic/other 
records 
 
Self-reported stroke/TIA 
or prior hospitalizations 
for these events 
Age, education, current smoking OR = 1.70 (0.28-
10.33)* 
0.563a 
Chen, 2011 [23] GMS-AGECAT, 
psychiatrist diagnosis or 
cause of death 
 
Doctor-diagnosed stroke Age, sex OR = 1.04 (0.31-
3.44) 
0.956 
Clerici, 2012[24] DSM-IV criteria History of stroke or TIA Age, sex, education, APOE, Cumulative 
Illness Rating Scale, MMSE, MCI subtype 
HR = 1.4 (0.8-2.5) NR 
 
Corraini, 2017 [25] ICD-8: 290.10, 290.09, 
293.09, 293.19, 094.19, 
290.11-290.19, 292.09 
and ICD-10: F00, G30, 
F01, F02-F03, F1x.73 
series, G23.1, G31.0, 
G31.0A, G31.0B, G31.1, 
G31.8B, G31.8E, G31.85 
ICD-8: 433-434, 431, 430, 
436 and ICD-10: I63, I61, 
I60, I64 
confirmed by brain 
imaging 
Diabetes, atrial fibrillation, hypertension, 
smoking, 
hyperlipidemia/hypercholesterolemia, 
myocardial infarction/ heart failure/ 
peripheral vascular disease, traumatic brain 
injury, depression, substance abuse  
HR = 1.67 (1.61-
1.73) 
 
NR 
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Crooks, 2008 [26] Multistage approach 
based on TICS-m, TDQ 
and medical records 
 
Self-reported stroke 
history 
None HR = 2.32 (1.63-
3.29) 
NR 
de Bruijn, 2015 
[27] 
Adjudicated, DSM-III-R 
criteria 
Stroke history based on 
home interviews and 
medical records 
Age, sex, education BMI, hypertension, 
diabetes, total cholesterol/HDL ratio, lipid-
lowering medication, smoking, coronary 
heart disease, heart failure, atrial fibrillation 
Original cohort: 
HR = 1.43 (1.00-
2.04) 
Extended cohort: 
HR = 1.70 (0.86-
3.37) 
 
NR 
 
 
NR 
DeCarli, 2004 [28] CDR score ≥1 Self- or informant 
reported stroke history 
and medical records 
review 
None HR=0.44 (0.10- 
1.95)* 
0.28* 
Desmond, 2002 
[29] 
DSM-III-R criteria Diagnosis of ischemic 
stroke confirmed by brain 
imaging 
Age, sex, education, ethnicity, MMSE HR = 3.83 (2.14-
6.84)† 
NR 
Dodge, 2011 [30] Adjudicated based on 
DSM-III criteria and 
CERAD 
 
Self-reported history of 
stroke or TIA 
Age, sex, education, recruitment status 
(random/volunteer) 
HR = 2.11 (1.18-
3.77) 
0.01 
Downer, 2016 [31] Alzheimer’s 
Association and National 
Institute on Aging 
Workgroup criteria 
Self-reported stroke 
history 
Age, sex, education HR = 0.77 (0.41-
1.44)* 
0.41* 
Ganguli, 2015[32] CDR score ≥1 Self-reported stroke 
history 
Age, sex, education HR = 2.14 (0.91-
5.06) 
Dementia onset age 
≤87 y: 
HR = 3.82 (1.25-
11.65) 
Dementia onset 
age>87 y: 
HR = 1.19 (0.28-
5.01) 
 
NR 
 
 
 
<0.05 
 
 
 
NR 
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Hassing, 2009[33] Adjudicated, DSM-III-R 
criteria 
Self-reported stroke 
history or review of 
medical records 
Age, sex, education, smoking, alcohol 
consumption, BMI, hypertension, congestive 
heart failure, myocardial infarction, diabetes 
OR = 1.54 (1.09-
2.17)* 
0.014* 
Hayden, 2006 [34] Adjudicated, DSM-III-R 
criteria 
Self- or informant 
reported stroke history 
Age, sex, education, APOE, hypertension, 
high cholesterol, diabetes, obesity, CABG, 
myocardial infarction 
HR = 3.23 (1.74-
5.64) 
NR 
Hendrie, 2015[35] Adjudicated, ICD-10 and 
DSM-IV-TR criteria 
Self-reported stroke 
history 
Age at diagnosis, sex, education, APOE, 
statin use at baseline 
OR = 2.06 (1.05-
4.02) 
0.0347* 
Hobson,  2010 [36] DSM-IV criteria First stroke based on 
clinical history, clinical 
examination and 
neuroimaging 
Baseline dementia RR = 2.14 (0.64-
7.13) 
NR 
Hsu, 2017 [37] Medical records, ICD-9-
CM: 331.0, 290.0-290.4 
Self-reported stroke 
history and stroke during 
study 
Age, sex, education, MCI, BMI, sleep 
problems, alcohol consumption, DBP, CRP 
HR = 1.38 (0.82-
2.31) 
0.2234 
 
 
Jin, 2008 [38] Adjudicated, DSM-III-R 
criteria 
Self- or informant-
reported stroke history, 
medical records or clinical 
examination 
Age, sex, education, SBP, diabetes mellitus see Table 2‡ see Table 2‡ 
Kokmen, 1996[39] Evidence of previous 
normal functioning, 
irreversible decline of 
intellectual/cognitive and 
social function, memory 
impairment, impaired 
functioning and ≥2 of the 
following: disorientation, 
personality or behavioural 
problems, dyscalculia, 
aphasia, apraxia or 
agnosia, and impaired 
judgement or abstract 
thinking in medical 
records 
Evidence of acute focal 
neurologic deficit (>24h) 
and no intracerebral 
haemorrhage in medical 
records  
Age, sex SMR = 3.2 (2.8-
3.7) 
NR 
Kuller, 2003[40] Adjudicated, evidence of 
progressive or static 
cognitive impairment in 2 
domains affecting 
activities of daily living 
NR Age, sex, ethnicity, education, 3MSE, 
APOE, white matter grade, ventricular size, 
large infarcts, any subclinical disease, 
diabetes, hypertension, myocardial 
infarction, angina  
HR = 1.2 (0.84-
1.82) 
NR 
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and previous normal 
intellectual function 
Li, 1991[41] Modified DSM-III criteria 
based on 
clinical/diagnostic 
evaluation and informant 
interview in case of death 
NR Age RR = 5.75 (NR) <0.05 
Liebetrau, 
2003[42] 
Medical records, DSM-
III-R criteria 
Self-, informant-reported, 
medical records (ICD-9: 
430-438) or death 
certificates 
None RR = 0.98 (0.4-2.2) NR 
Noale, 2013 [43] DSM-III-R criteria WHO definition. self-
reported stroke diagnosis 
or neurological symptoms 
or ≥1 positive test of a 
short neurological 
evaluation and review of 
clinical record and/or 
diagnosis by the study 
neurologist 
Age, sex, education, triglycerides, HDL 
cholesterol, glycaemia, BMI, heart failure, 
parkinsonism, depressive symptomatology, 
family history of dementia 
HR = 1.14 (0.51-
2.57)* 
0.7510* 
Peters, 2009 [53] Adjudicated, DSM-IV 
criteria 
ICD-10: I60-I64 Sex, geographical recruitment area, 
randomised trial treatment group, BMI, heart 
failure, diabetes, atrial fibrillation, total 
cholesterol, HDL, creatinine, glucose, 
haemoglobin 
HR = 1.459 (0.928-
2.295) 
NR 
Qiu, 2010 [44] DSM-III-R criteria Medical records, ICD-8,9: 
430-438 
Age, sex, education, APOE, follow-up 
survival status, baseline MMSE score, BMI, 
coronary heart disease, BP lowering drugs, 
systolic pressure, diastolic pressure, pulse 
pressure, diabetes/prediabetes, heart failure 
HR = 1.49 (1.05-
2.11) 
NR 
Simons, 2006 [45] Medical records, ICD-9-
CM or ICD-10-AM 
Self-reported history Age, sex HR = 1.50 (0.98-
2.29) 
NR 
Srikanth, 2004 [46] DSM-IV criteria WHO definition Age, baseline S-MMSE OR = 1.31 (0.48-
3.62) 
0.59 
Srikanth, 2006 [47] DSM-IV criteria WHO definition None With recurrent 
stroke: 
RR = 4.5 (1.9-10.6) 
Without recurrent 
stroke: 
 
 
 
0.003 
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RR = 1.7 (0.7-4.1)  
 
0.20 
Tsai, 2017 [48] Medical records, ICD-9-
CM: 290, 294.1, 331.0 
Medical records, ICD-9-
CM: 430-438 
Age, sex, acute kidney injury, diabetes, 
hypertension, hyperlipidemia, head injury, 
depression, chronic obstructive pulmonary 
disease, coronary artery disease, congestive 
heart failure, atrial fibrillation, cancer, liver 
disease, chronic infection/inflammation, 
autoimmune disease, malnutrition 
HR = 2.63 (2.36-
2.93) 
<.001 
Unverzagt, 2012 
[54] 
Any of the following: 
memory and reasoning, 
speed or vocabulary 21.5 
SD below the ACTIVE 
sample baseline mean and 
functional at or below the 
10th percentile of the 
ACTIVE sample baseline 
or, first and all subsequent 
visits’ MMSE<22 or are 
missing. or, self- or 
proxy-report 
of diagnosis of dementia 
or AD during follow-up 
or, interval self- or proxy-
report of 
institutionalization during 
follow-up or, deactivation 
from the study due to 
family refusing access to 
subject 
Self-reported stroke or 
TIA history 
Age, sex, ethnicity, marital status, training 
group, alcohol consumption, MMSE, 
physical function, depressive symptoms, 
diabetes 
HR = 1.23 (0.76-
2.00) 
0.4 
Walters, 2016 [49] ICD-10 dementia 
diagnoses including AD, 
vascular dementia, and 
unspecified or mixed 
dementia 
ICD-10 diagnosis of 
stroke/TIA history 
Age, age2, sex, calendar year, deprivation, 
BMI, BMI2, current anti-hypertensive use, 
smoking, alcohol problem history, diabetes 
history, current depression/use of anti-
depressants, atrial fibrillation history, current 
aspirin 
 
Aged 60-79: 
HR = 1.78 (1.65-
1.92) 
 
 
 
 
 
 
NR 
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Age, age2, sex, calendar year, deprivation, 
BMI, current anti-hypertensive use, systolic 
BP, lipid ratio, smoking, alcohol problem 
history, diabetes history, atrial fibrillation 
history, current depression/use of anti-
depressants, current anxiety/use of 
anxiolytics, current NSAID use, current 
aspirin use 
Aged 80-95: 
HR = 1.27 (1.19-
1.36) 
 
NR 
Yamada, 2009[50] Adjudicated, DSM-IV 
criteria 
NR Age, age2, education, grip strength, BMI, 
smoking, drinking, menopausal age, history 
of hypertension and diabetes 
RR = 1.92 (NR) NR 
Yip, 2006 [51] Score of 3–5 on the 
AGECAT 
diagnostic algorithm 
Self-reported stroke 
history 
Age, sex, education, social class OR = 2.1 (1.1-4.2) NR 
Zahodne, 2016 [52] Adjudicated Self-reported stroke 
history 
Age, sex, education, ethnicity, depression, 
hypertension, diabetes, heart disease, APOE, 
memory trajectories 
 OR = 1.37 (1.10-
1.71) 
<0.05 
AD,Alzheimer’s disease; AGECAT,Automated Geriatric Examination for Computer Assisted Taxonomy; APOE,Apolipoprotein E;  BMI,body-mass index; BP,blood 
pressure; CABG,coronary artery bypass graft surgery; CAMDEX,Cambridge Examination for Mental Disorders in the Elderly; CDR,Clinical Dementia Rating; 
CERAD,Consortium to Establish a Registry for Alzheimer’s Disease; CI,confidence interval; CRP,C-reactive protein; DBP,diastolic blood pressure; DSM,Diagnostic and 
Statistical Manual of Mental Disorders; FHS,Framingham Heart Study; GMS-AGECAT,Geriatric Mental State – Automated Geriatric Examination for Computer Assisted 
Taxonomy; HDL,high-density lipoprotein; HR,hazard ratio; HRS,Health and Retirement Study; ICD,International Classification of Diseases; MCI,mild cognitive 
impairment; MMSE,Mini-Mental State Examination; NSAID,non-steroidal anti-inflammatory drugs; NR,not reported; OR,odds ratio; RR,risk ratio; SALSA,Sacramento 
Area Latino Study on Aging; SBP,systolic blood pressure; S-MMSE,Standardized Mini-Mental State Examination; SMR,standardized morbidity ratio; TDQ,Telephone 
Dementia Questionnaire; TIA, transient ischemic attack; TICS-m,Telephone Interview for Cognitive Status-modified; WHO,World Health Organization; 3MSE,Modified 
Mini-Mental State Examination. *Additional information provided by the authors. †Results of Cox proportional hazards regression reported as risk ratio. ‡Results reported 
only for a joint effect of stroke and APOE on incident dementia. 
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Table B4. Results of included studies for the association between incident stroke and incident all-cause dementia 
Study Dementia 
assessment/diagnosis 
Stroke 
assessment/diagnosis 
Adjustment Effect size (95% CI) P value 
Dregan, 2013 [55] Self- or informant 
reported diagnosis 
Self-reported diagnosis Age, sex, education, 
marital status, social 
class, diabetes mellitus, 
hypertension, smoking, 
depression, physical 
activity 
RR = 2.63 (1.80-3.84) <0.001 
Gamaldo, 2006 [56] Adjudicated, DSM-III-R 
criteria 
Self- or informant-
reported stroke history 
confirmed by medical 
records and autopsy in 
some cases 
Age, sex, hypertension, 
diabetes, coronary artery 
disease, cholesterol, 
APOE  
 
Age, sex 
OR = 4.34 (1.75-10.83) 
 
 
 
 
Cognitively normal 
before stroke: 
OR = 1.1 (0.37-3.34) 
Cognitive symptoms 
before stroke, no 
dementia: 
OR = 41.0 (5.1-328) 
 
<0.05 
 
 
 
 
 
 
NR 
 
 
 
NR 
Hsu, 2017 [37] Medical records, ICD-9-
CM: 331.0, 290.0-290.4 
Self-reported stroke 
history and stroke during 
study 
Age, sex, education, 
MCI, BMI, sleep 
problems, alcohol 
consumption, diastolic 
BP, CRP 
HR = 1.79 (1.27-2.52) 0.0008 
Ivan, 2004 [57] Adjudicated, DSM-IV 
criteria 
Acute focal neurological 
deficit lasting >24 hours 
Age, sex, education, 
second stroke, 
hypertension, diabetes, 
atrial fibrillation, current 
smoking 
 
Sex, education, right/left 
hemisphere, 
atherothrombotic brain 
infarcts, second stroke 
HR = 2.4 (1.6-3.7)  
 
 
 
 
 
Aged <80 
HR = 2.6 (1.5-4.5) 
Aged ≥80 
HR = 1.6 (1.0-2.6)  
<0.001 
 
 
 
 
 
 
<0.001 
 
0.075 
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Jin, 2006 [58] Adjudicated, DSM-III-R 
criteria or cause of death 
by ICD-9 codes (331.0, 
331.1, 290, 290.0, 290.2, 
290.3, 290.4, 290.8, 
290.9, 294.1, 046.1)  
Self- or informant-
reported or cause of death 
by ICD-9 codes (431, 434, 
434.0, 434.1, 434.9, 436, 
437, 437.1, 437.2, 437.9, 
997.02)  
None HR = 2.3 (1.3-4.1) NR 
Kim, 2017 [59] Medical records, ICD-10: 
F01-F03, G30, G31.1 
Medical records, ICD-10: 
I69.0-I69.9 
Age, sex, Charlson 
Comorbidity Index, 
residential region, route 
of admission, income 
HR = 2.37 (2.23-2.51) <0.001 
Li, 2010 [60] Medical records, ICD-9: 
291, 294, 331.0 
Medical records, ICD-9: 
430-434 
Age, cardiovascular 
disease, cardiovascular 
drugs, diabetes 
HR = 2.56 (2.51-2.61) <0.001 
Liebetrau, 2003 [42] Medical records, DSM-
III-R criteria 
Self-, informant-reported, 
medical records (ICD-9: 
430-438) or death 
certificates 
None RR= 3.8 (2.2-6.7) NR 
Mirza, 2016 [15] Adjudicated, DSM-III-R 
criteria 
Stroke or TIA, medical 
records, WHO definition 
Age, sex, education, 
study cohort, MMSE, 
BMI, smoking, total 
cholesterol, HDL 
cholesterol, lipid-
lowering medication, 
systolic BP, diastolic BP, 
BP-lowering medication, 
diabetes 
HR = 1.42 (1.20-1.67) NR 
Nordstrom, 2013 [61] Medical records, ICD-8 or 
ICD-10: F00.X, G30.X, 
290.X, F01.X, F10.7A, 
F03.9, F02.3, G31.8A  
Medical records, ICD-8 or 
ICD-10: I63.X, 433, 434 
Age, education weight, 
height, knee strength, BP, 
baseline cognitive 
function, parental 
dementia, annual income, 
alcohol intoxication, drug 
intoxication, depression 
or use of antidepressants, 
myocardial infarction, 
neuroleptics, antidiabetics  
HR = 2.96 (2.02-4.35) NR 
Rastas, 2010 [62] Adjudicated, DSM-III-R 
criteria 
TIA or stroke in medical 
records, focal signs of 
Age, sex, education, 
APOE, HDL cholesterol, 
HR = 3.28 (1.92-5.62) <0.001 
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stroke confirmed by a 
neurologist 
LDL cholesterol, 
triglycerides, 
homocysteine, diabetes, 
hypertension, systolic and 
diastolic BP, baseline 
stroke 
Zhu, 2000 [63] DSM-III-R criteria Medical records, ICD-8: 
430-438 
Age, sex, education, heart 
disease, systolic BP, 
antihypertensive 
medication 
HR = 2.4 (1.6-3.5)* NR 
BMI, body-mass index; BP, blood pressure; CI, confidence interval; HDL, high-density lipoprotein; HR, hazard ratio; ICD, International Classification of Diseases; ICPC, 
International Classification of Primary Care; LDL, low-density lipoprotein; NR, not reported; RR, risk ratio; TIA, transient ischemic attack.  
*Results of Cox proportional hazards regression reported as risk ratio. 
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Table B5. Quality assessment of included studies 
Study  Selection bias Study design Confounders  Blinding Data collection 
method 
Withdrawals 
and drop-outs  
Global rating  
Aguilar-Navarro, 2017 
[19] 
moderate moderate strong moderate strong moderate strong 
Barnes, 2014 [20] moderate moderate strong moderate strong weak moderate 
Brayne, 1998 [21] moderate moderate weak moderate strong weak weak 
Bruce, 2014 [22] weak moderate moderate moderate strong strong moderate 
Chen, 2011 [23] strong moderate weak moderate strong strong moderate 
Clerici, 2012 [24] moderate moderate strong moderate strong strong strong 
Corraini, 2017 [25] moderate moderate moderate moderate  weak moderate moderate 
Crooks, 2008 [26] weak moderate weak moderate moderate moderate weak 
de Bruijn, 2015 [27] moderate moderate strong moderate strong strong strong 
DeCarli, 2004 [28] weak moderate weak moderate weak strong weak 
Desmond, 2002 [29] weak moderate moderate moderate moderate strong moderate 
Dodge, 2011 [30] moderate moderate moderate moderate strong weak moderate 
Downer, 2016 [31] moderate moderate weak moderate strong strong moderate 
Dregan, 2013 [55] moderate moderate strong moderate  weak moderate moderate 
Gamaldo, 2006 [56] weak moderate strong moderate strong moderate moderate 
Ganguli, 2015 [32] strong moderate weak moderate  weak strong weak 
Hassing, 2009 [33] moderate moderate strong moderate  weak moderate moderate 
Hayden, 2006 [34] strong moderate strong moderate strong moderate strong 
Hendrie, 2015 [35] moderate moderate strong moderate  strong moderate strong 
Hobson, 2010 [36] moderate moderate weak moderate strong weak weak 
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Hsu, 2017 [37] moderate moderate strong moderate  weak moderate moderate 
Ivan, 2004 [57] moderate moderate strong moderate  strong weak moderate 
Jin, 2006 [58] moderate moderate weak moderate strong strong moderate 
Jin, 2008 [38] moderate moderate strong moderate  strong strong strong 
Kim, 2017 [59] moderate moderate strong moderate  weak moderate moderate 
Kokmen, 1996 [39] moderate moderate weak moderate weak moderate weak 
Kuller, 2003 [40] moderate moderate strong moderate  strong strong strong 
Li, 1991 [41] strong moderate weak moderate  strong moderate moderate 
Li, 2010 [60] weak moderate  moderate moderate  moderate  weak weak 
Liebetrau, 2003 [42] moderate moderate weak moderate weak moderate weak 
Mirza, 2016 [15] moderate moderate strong moderate  strong strong strong 
Noale, 2013 [43] strong moderate strong moderate strong moderate strong 
Nordström, 2013 [61] weak moderate  strong weak moderate  strong weak 
Peters, 2009 [53] weak moderate  strong moderate  strong strong moderate 
Qiu, 2010 [44] moderate moderate Strong  moderate  strong strong strong 
Rastas, 2010 [62] strong moderate strong moderate strong strong strong 
Simons, 2006 [45] moderate moderate weak moderate weak strong weak 
Srikanth, 2004 [46] moderate moderate weak moderate  strong strong moderate 
Srikanth, 2006 [47] moderate moderate weak moderate  strong strong moderate 
Tsai, 2017 [48] moderate moderate strong moderate  moderate moderate strong 
Unverzagt, 2012 [54] moderate moderate strong moderate  strong strong strong 
Walters, 2016 [49] moderate moderate strong moderate  moderate moderate strong 
Yamada, 2009 [50] weak moderate  strong moderate  strong strong moderate 
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Yip, 2006 [51] moderate moderate moderate moderate strong moderate strong 
Zahodne, 2016 [52] moderate moderate strong moderate  weak moderate moderate 
Zhu, 2000 [63] moderate moderate strong moderate  strong strong strong 
  
 
 
 
 
Table B6. Results of included studies for the association between prevalent or incident stroke and incident all-cause dementia stratified by sex 
Study (year) Male Female 
 Adjustment Effect size 
(95% CI) 
P value Adjustment Effect size 
(95% CI) 
P value 
Prevalent stroke 
Corraini et al 
(2017)25 
None HR = 2.06 
(2.00-2.12) 
NR None HR = 1.61 
(1.57-1.66) 
NR 
Noale et al 
(2013)43 
Age, triglycerides, HDL cholesterol, 
heart failure, parkinsonism, depressive 
symptomatology, family history of 
dementia 
HR = 1.19 
(0.47-3.01) 
0.7155 Age, education, BMI, glycaemia, triglycerides, 
heart failure, parkinsonism, depressive 
symptomatology 
HR = 1.07 
(0.31-3.70) 
0.9102 
Incident stroke 
Ivan et al 
(2004)57 
Age, education, right/left hemisphere, 
atherothrombotic brain infarcts, second 
stroke 
HR = 2.7 (1.4-
5.2) 
0.002 Age, education, right/left hemisphere, 
atherothrombotic brain infarcts, second stroke 
HR = 1.7 (1.1-
2.7) 
0.018 
BMI, body-mass index; CI, confidence interval; HDL, high-density lipoprotein; HR, hazard ratio; NR, not reported.  
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Appendix B - Figures  
 
 (A) 
 
 
(B) 
 
 
(C) 
 
Fig. B4. Funnel plots 
The figure shows the funnel plots for the meta-analysis of prevalent stroke combining studies with hazard ratios 
estimates (A) and odds ratios (B), and the meta-analysis of incident stroke combining studies with risk ratios 
estimates (C) of incident all-cause dementia.
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Fig. B5.1 Meta-analysis of hazard ratios of prevalent stroke compared to no prevalent stroke on incident 
all-cause dementia excluding four studies including subjects with mild cognitive impairment 
Data presented as hazard ratios with corresponding weight for each study in the meta-analysis because number of 
stroke events, dementia cases and total number of participants was not always available in original included 
studies. Hazard ratio estimate for the study by Hayden and colleagues [34] was obtained in Review Manager using 
the generic inverse-variance method and is different from that obtained from a discrete-time survival model 
reported in the original study (i.e. HR = 3.23, CI = 1.74-5.64). IV, inverse-variance estimation method; CI, 
confidence interval; EC, extended cohort; FHS, Framingham Heart Study; HRS, Health and Retirement Study; 
OC, original cohort; SALSA, Sacramento Area Latino Study on Aging. 
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Fig. B5.2 Meta-analysis of hazard ratios of prevalent stroke compared to no prevalent stroke on incident 
all-cause dementia excluding six studies with transient ischemic attack included in the definition of stroke 
Data presented as hazard ratios with corresponding weight for each study in the meta-analysis because number of 
stroke events, dementia cases and total number of participants was not always available in original included 
studies. Hazard ratio estimate for the study by Hayden and colleagues34 was obtained in Review Manager using 
the generic inverse-variance method and is different from that obtained from a discrete-time survival model 
reported in the original study (i.e. HR = 3.23, CI = 1.74-5.64). IV, inverse-variance estimation method; CI, 
confidence interval; EC, extended cohort; FHS, Framingham Heart Study; HRS, Health and Retirement Study; 
OC, original cohort; SALSA, Sacramento Area Latino Study on Aging. 
 
 
 
 
 
 
Fig. B5.3 Meta-analysis of unadjusted risk ratios of prevalent stroke compared to no prevalent stroke on 
incident all-cause dementia  
Data presented as risk ratios with corresponding weight for each study in the meta-analysis because number of 
stroke events, dementia cases and total number of participants was not always available in original included 
studies. IV, inverse-variance estimation method; CI, confidence interval.
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Fig. B6.1 Meta-analysis of adjusted risk ratios of incident stroke compared to no incident stroke on incident 
all-cause dementia excluding three studies with transient ischemic attack included in the definition of stroke 
Data presented as risk ratios with corresponding weight for each study in the meta-analysis because number of 
stroke events, dementia cases and total number of participants was not always available in original included 
studies. IV, inverse-variance estimation method; CI, confidence interval. 
 
 
 
 
 
Fig. B6.2 Meta-analysis of unadjusted risk ratios of incident stroke compared to no incident stroke on 
incident all-cause dementia 
Data presented as risk ratios with corresponding weight for each study in the meta-analysis because number of 
stroke events, dementia cases and total number of participants was not always available in original included 
studies. IV, inverse-variance estimation method; CI, confidence interval. 
 
 
 
